VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 149 filers reported holding VENTYX BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,549,717 | +15.7% | 418,938 | +9.3% | 0.00% | +50.0% |
| Q2 2023 | $12,574,110 | +69.3% | 383,357 | +72.9% | 0.00% | +100.0% |
| Q1 2023 | $7,428,424 | +4.9% | 221,744 | +2.6% | 0.00% | 0.0% |
| Q4 2022 | $7,084,805 | +10.3% | 216,066 | +17.5% | 0.00% | 0.0% |
| Q3 2022 | $6,421,000 | +215.1% | 183,936 | +10.4% | 0.00% | – |
| Q2 2022 | $2,038,000 | +74.2% | 166,643 | +93.2% | 0.00% | – |
| Q1 2022 | $1,170,000 | -36.9% | 86,252 | -7.6% | 0.00% | – |
| Q4 2021 | $1,854,000 | – | 93,365 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 2,298,833 | $77,010,906 | 42.68% |
| Qiming U.S. Ventures Management, LLC | 746,370 | $25,003,395 | 30.26% |
| TCG Crossover Management, LLC | 815,724 | $27,326,754 | 5.33% |
| ACUTA CAPITAL PARTNERS, LLC | 208,500 | $6,984,750 | 5.15% |
| Affinity Asset Advisors, LLC | 260,008 | $8,710,268 | 2.88% |
| Avidity Partners Management LP | 1,917,800 | $64,246,300 | 2.13% |
| Integral Health Asset Management, LLC | 290,000 | $9,715,000 | 1.96% |
| Tri Locum Partners LP | 152,842 | $5,120,207 | 1.56% |
| Vivo Capital, LLC | 602,075 | $20,169,513 | 1.40% |
| Boxer Capital, LLC | 850,000 | $28,475 | 1.40% |